Loading...
XTAE
EMTC-M
Market cap5mUSD
Oct 08, Last price  
18.50ILS
1D
0.00%
1Q
-8.42%
Jan 2017
18,972.16%
Name

Elbit Medical Technologies Ltd

Chart & Performance

D1W1MN
P/E
6.24
P/S
—
EPS
0.01
Div Yield, %
—
Shrs. gr., 5y
-17.09%
Rev. gr., 5y
112.53%
Revenues
0k
-100.00%
000000000054,000271,0000
Net income
827k
P
38,745,000-11,754,000-9,378,000-15,524,000-18,654,000-10,752,00026,821,000-21,220,000123,046,000-15,520,000-5,111,000-17,794,000827,000
CFO
-542k
L-8.14%
-17,066,000-336,000-443,000-261,000-293,000-301,000-190,000-571,000-674,000-547,000-526,000-590,000-542,000

Profile

Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of therapeutic medical systems in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurological disorders and tumors. It is also involved in the study and development of medical products based on stem cells originating primarily from the umbilical cord blood that are used for bone marrow transplants in the patients of leukemia or cancer of lymph nodes, non-malignant blood diseases, and metabolic genetic disorders. The company is based in Petah Tikva, Israel. Elbit Medical Technologies Ltd is a subsidiary of Exigent Management Ltd.
URL
elbitimaging.com
IPO date
Jul 27, 1993
Employees
662
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
271
401.85%
54
 
Cost of revenue
38,895
51,742
35,731
Unusual Expense (Income)
NOPBT
(38,895)
(51,471)
(35,677)
NOPBT Margin
Operating Taxes
(556)
Tax Rate
NOPAT
(38,895)
(51,471)
(35,121)
Net income
827
-104.65%
(17,794)
248.15%
(5,111)
-67.07%
Dividends
Dividend yield
Proceeds from repurchase of equity
(411)
BB yield
82.35%
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(1,264)
(7,405)
(23,525)
Cash flow
Cash from operating activities
(542)
(590)
(526)
CAPEX
Cash from investing activities
164
2,020
(1,958)
Cash from financing activities
(411)
FCF
(38,895)
(51,471)
(35,121)
Balance
Cash
1,264
1,649
2,253
Long term investments
5,756
21,272
Excess cash
1,264
7,391
23,522
Stockholders' equity
(74,632)
(75,459)
55,096
Invested Capital
82,676
82,676
1,489
ROIC
ROCE
EV
Common stock shares outstanding
90,716
90,716
90,738
Price
0.14
5,417.24%
0.00
-52.55%
0.01
-68.75%
Market cap
13,063
5,417.24%
237
-52.56%
499
-68.17%
EV
11,799
(7,168)
(23,026)
EBITDA
(38,895)
(51,471)
(35,677)
EV/EBITDA
0.14
0.65
Interest
Interest/NOPBT